Mirakof SR Tablet
by Square Pharmaceuticals Limited
৳10.00
Opsonin Pharma Limited
Butaret SR 50 tablet from Opsonin Pharma & Generic is Butamirate Citrate 50mg. Butamirate Citrate is used to relieve dry (non-productive) cough. Dry cough may be caused by a recent viral infection. It is also used for pre- & post-operative cough sedation in patients who will undergo surgical procedures and bronchoscopy. It can be used in acute cough of any etiology, whooping cough and cough due to acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis) etc.
Butamirate Citrate is utilized to diminish dry (non-productive) hack. Dry hack may be caused by a later viral disease. Butamirate Citrate is additionally utilized for pre & post-operative hack sedation in patients who will experience surgical strategies and bronchoscopy. It can be utilized within the intense hack of any etiology, whooping hack and hack due to intense lower respiratory tract contaminations (tracheitis, laryngitis, bronchitis) etc.
Butamirate Citrate acts specifically on the brain's hack center to smother hack. Butamirate Citrate is secure and non-sedating which is not one or the other chemically nor pharmacologically related to opium alkaloids. Butamirate Citrate is quickly and totally retained after verbal organization. Most extreme concentration is come to inside 9 hours with the sustained-release tablet. This can be greatly protein-bound and plasma end half-life is around 13 hours. The dynamic metabolites of Butamirate Citrate have moreover antitussive activity.
Use in adult:
Use in children & adolescents:
Butamirate Citrate 50 mg tablet:
Butamirate Citrate syrup:
Butamirate Citrate pediatric drops:
Concomitant use with expectorants should be avoided.
Hypersensitivity to the active ingredient.
The tolerance of Butamirate Citrate is good.Adverse reactions such as rash,nausea,diarrhoea and vertigo have been observed in a few rare cases,resolving after dose reduction or treatment withdrawal.
Butamirate Citrate should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Butamirate Citrate administration during breast feeding should be carefully weighed against the risks.
Butamirate Citrate suppresses the cough reflex and therefore the concomitant use with expectorants should be avoided, since it may lead to mucus retention in the airways, which increases the risk of bronchospasm and respiratory infections. If the cough persists for more than 7 days (more than 3 days in children younger than12 years of age) doctor must be consulted.
Cough suppressant
Protect from light and moisture by storing below 30°C. Keep the medicine out of children's reach.
by Delta Pharma Limited
৳10.00